Expert in Nanobiotechnology, Drug Delivery Platforms, Medical Devices, Targeted Therapeutics, Diagnostics
Expert has over 10 years of direct involvement with start-up and early-stage biotechnology companies in a variety of fields including nanotechnology, medical imaging, medical devices, biomaterials, antibacterials, and cancer medicines.
Over the last 10 years, Expert has developed many innovative approaches and solutions to optimize the delivery of medicines in order to improve their potency and reduce their side-effects. Using his technological insight novel drug candidates that normally would otherwise fail due to poor pharmacological properties can be formulated in delivery vehicles rendering them into promising medicines.
Expert applied his knowledge in protein biochemistry to isolation and purification challenges of protein therapeutics and other biotechnological relevant proteins.
Assessment of emerging bioscience technologies.Provided insight and strategic advice to formulation, targeting, and biological evaluation of nanoparticle-based product candidates.Contributed expertise to several start-up companies.Advised the regional headquarters (EMRO) of the World Health Organization on establishing an antimicrobial surveillance network in the Middle East.
Expert may consult nationally and internationally, and is also local to the following cities: San Jose, California - San Francisco, California - Sacramento, California - Oakland, California - Stockton, California - Fremont, California - Modesto, California - Salinas, California - Santa Rosa, California - Hayward, California
|Year: 1993||Degree: PhD||Subject: Biochemistry||Institution: Biocenter, University of Basel|
|Year: 1989||Degree: MS||Subject: Plant Physiology||Institution: Albert-Ludwigs University Freiburg|
|Years: 2006 to Present||Employer: Undisclosed||Title: Consultant||Department:||Responsibilities: Expert in the assessment of emerging bioscience technologies.
Advanced knowledge of the emerging field of nanobiotechnology.
Contributed expertise to several start-up companies.
|Years: 2007 to 2008||Employer: Cerus Corp.||Title: Global Scientific Affairs Manager||Department:||Responsibilities: Scientific promotion of company’s blood safety products for pathogen inactivation through publications and establishment of global support by key opinion leaders.
Develop and execute post-marketing studies to enhance marketability of product portfolio.
|Years: 2006 to 2007||Employer: Nanomix, Inc.||Title: Senior Scientist, Technical Lead||Department:||Responsibilities: Developed to beta prototype stage an emergency respiratory medical device product for the measurement of carbon dioxide.
Provided solutions for key issues with protein formulation/analysis, and device shelf-life optimization.
|Years: 1999 to 2006||Employer: Alnis BioSciences, Inc.||Title: Principal Scientist||Department:||Responsibilities: Achieved development and implementation of assays and analytical methods in support of in vitro testing and pharmacokinetics/-dynamics.
Advanced the preclinical development of targeted antibacterial and anti-cancer therapeutics, and tumor imaging agents.
Established a project to formulate nanoparticle-encapsulated antibacterials with increased potency.
Co-authored proposals for funding that resulted in 2 contracts with the NIH worth $4.5 millions.
Served as scientific liaise and managed effective collaborations with academic research groups, contract research organizations, and consultants.
Managed isolation and purification of bacterial proteins and toxins as templates for artificial antibodies in a DARPA-funded project.
Provided expertise in setting up the company’s biology laboratory and supervised/ensured its operation.
|Years: 1997 to 1999||Employer: GlaxoSmithKline||Title: Senior Scientist||Department:||Responsibilities: Contributed to the design and implementation of optimization strategies for antibacterial lead compounds in collaboration with the Medicinal Chemistry department.
Supported the development of automated assays to increase compound throughput and characterization of antibacterial leads.
Impacted the development of FTIR-based techniques to characterize the antibiotic resistance profile of bacterial pathogens.
|Years: 1995 to 1997||Employer: National Institute of Health and the Environment, Holland||Title: Research Fellow||Department:||Responsibilities: Recipient of a fellowship of the European Union.
Co-founder of the European Network for Antimicrobial Resistance and Epidemiology (ENARE).
Development of diagnostic techniques for the genotypic characterization of pathogens and identification of resistance.
|Years: 1996 to 1996||Employer: World Health Organisation||Title: Consultant||Department:||Responsibilities: Field visit to Beirut. Provided critical advice and support to establish a surveillance network for antimicrobial resistance in Lebanon.
Authored comprehensive report for and published by the WHO.
|Years||Country / Region||Summary|
|Years: 2008 to 2008||Country / Region: United Arab Emirates/Dubai||Summary: Expert provided initial advisory to clients about establishing a research infrastructure for nanobiotechnology.|
|Years: 2008 to 2008||Country / Region: United Arab Emirates/Sharjah||Summary: Expert consulted for the Ministry of Health about the introduction of novel technologies to improve the safety for human health of medical products.|
|Years: 1996 to 1996||Country / Region: Lebanon/Beirut||Summary: Expert consulted for the Eastern Mediterranean Regional Office of the World Health Organization to establish WHO's worldwide surveillance network for antimicrobial resistance. He undertook visits to many of the regions clinical microbiology laboratories.|
|Years: 1998 to 1998||Country / Region: Egypt/Alexandria||Summary: Expert has an assignment with a pharmaceutical manufacturer of generic drugs about establishing an independent research and development program.|
|Associations / Societies|
|German American Business Association|
|Awards / Recognition|
|SmithKline-Beecham Award (1996)|
|Publications and Patents Summary|
|Over thirty publications and one patent in Formulations of Paramagnetic Ion Complexes
|German||Expert is a native German.|
|Italian||He lived in Italy for several years where he acquired his Italian language capabilities.|